Updated
Updated · Fox News · Jul 15
Tom Brady Tells 1 Raiders Rookie to Earn His Shot as He Pushes GLP-1 Access
Updated
Updated · Fox News · Jul 15

Tom Brady Tells 1 Raiders Rookie to Earn His Shot as He Pushes GLP-1 Access

1 articles · Updated · Fox News · Jul 15

Summary

  • Fernando Mendoza has not earned anything yet, Tom Brady said, dismissing offseason quarterback hype around the Raiders rookie and insisting he must prove himself with meaningful NFL play.
  • Brady said draft status and buzz matter less than work, adversity and teamwork, framing Mendoza like every other rookie who has yet to take a meaningful snap in the league.
  • The 48-year-old tied that message to his new role as eMed's chief wellness officer, where he says discipline, accountability and long-term habits also drive better health outcomes.
  • eMed CEO Linda Yaccarino said the company is expanding access to GLP-1 drugs and pairing them with AI and clinical support, citing a 90% adherence rate as it targets chronic conditions.

Insights

With Tom Brady and AI, can eMed's employer-focused model truly democratize access to revolutionary GLP-1 drugs?
eMed's platform promises huge savings, but what happens to patient health when their employer stops paying?
eMed boasts 90% adherence, but does its model create lifelong drug dependency for weight management?